Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications

Author:

Saleem ZikriaORCID,Haseeb AbdulORCID,Godman BrianORCID,Batool Narjis,Altaf Ummara,Ahsan Umar,Khan Faiz UllahORCID,Mustafa Zia UlORCID,Nadeem Muhammad Umer,Farrukh Muhammad Junaid,Mugheera Muhammad,Rehman Inaam Ur,Khan Asma Fareed,Saeed HamidORCID,Hossain Mohammad AkbarORCID,Raafat MohamedORCID,Radwan Rozan Mohammad,Iqbal Muhammad ShahidORCID

Abstract

The COVID-19 pandemic has significantly influenced antimicrobial use in hospitals, raising concerns regarding increased antimicrobial resistance (AMR) through their overuse. The objective of this study was to assess patterns of antimicrobial prescribing during the current COVID-19 pandemic among hospitals in Pakistan, including the prevalence of COVID-19. A point prevalence survey (PPS) was performed among 11 different hospitals from November 2020 to January 2021. The study included all hospitalized patients receiving an antibiotic on the day of the PPS. The Global-PPS web-based application was used for data entry and analysis. Out of 1024 hospitalized patients, 662 (64.64%) received antimicrobials. The top three most common indications for antimicrobial use were pneumonia (13.3%), central nervous system infections (10.4%) and gastrointestinal indications (10.4%). Ceftriaxone (26.6%), metronidazole (9.7%) and vancomycin (7.9%) were the top three most commonly prescribed antimicrobials among surveyed patients, with the majority of antibiotics administered empirically (97.9%). Most antimicrobials for surgical prophylaxis were given for more than one day, which is a concern. Overall, a high percentage of antimicrobial use, including broad-spectrums, was seen among the different hospitals in Pakistan during the current COVID-19 pandemic. Multifaceted interventions are needed to enhance rational antimicrobial prescribing including limiting their prescribing post-operatively for surgical prophylaxis.

Funder

Deanship of Scientific Research at the Umm Al-Qura University

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference134 articles.

1. A brief history of antibiotics and select advances in their synthesis;Nicolaou;J. Antibiot.,2018

2. History of Antibiotics. From Salvarsan to Cephalosporins;Zaffiri;J. Investig. Surg.,2012

3. Social ramifications of control of microbial disease;McDermott;Johns Hopkins Med. J.,1982

4. Miracle Cure: The Creation of Antibiotics and the Birth of Modern Medicine;Hamilton;Emerg. Infect. Dis.,2019

5. World Health Organization (2022, October 29). No Time to Wait: Securing the Future from Drug-Resistant Infections—Report to the Secretary-General of the United Nations. Available online: https://www.who.int/publications/i/item/no-time-to-wait-securing-the-future-from-drug-resistant-infections.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3